ClinicalTrials.Veeva

Menu

Molecular and Cellular Characterization of Skull Base Tumors

University of Pittsburgh logo

University of Pittsburgh

Status

Enrolling

Conditions

Skull Base Neoplasm
Cellular Pathology

Treatments

Other: Observation

Study type

Observational

Funder types

Other

Identifiers

NCT03759717
STUDY19070185

Details and patient eligibility

About

The purpose of the study is to analyze biological samples and genetic material for basic science research investigating the molecular and cellular characterization of skull base tumors.

Full description

The overall goal of this proposal is to determine new molecular and cellular features that define tumor subtypes that are clinically actionable, may drive important changes in patient management, and/or elucidate novel chemotherapeutic options. Skull base tumors are currently diagnosed based on histopathologic criteria, on which post-operative management is based. However, the investigators hypothesize that each tumor type (eg. chordoma or chondrosarcoma) will have molecular and/or cellular subcategories that will redefine how to categorize and diagnose patients, predict clinical outcome, and optimally design a patient-specific management strategy. In addition, we aim to catalogue changes that occur after treatment after surgical resection, chemotherapy, and/or radiation by comparing primary and recurrent tumors.

Enrollment

4,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of a skull base tumor

Exclusion criteria

  • Insufficient tumor sample at time of resection

Trial contacts and locations

1

Loading...

Central trial contact

Benita Valappil, MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems